← Leaderboards
Libin Xu
Vanderbilt University
$7,729,917
Attributed
$8,938,961
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2012–25$2.5M$1.9M$1.3M$625K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,938,961 · 8
By mechanism
R01$7,212,323 · 4
R00$744,509 · 1
R21$414,979 · 1
T32$352,624 · 1
K99$214,526 · 1
Top collaborators
- Brian James Werth3 shared
- William M Atkins1 shared
- Dan Fu1 shared
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionLipidsAffectPathway InteractionsBloodBiologicalSamplingInnovationLipid MetabolismCellsOxidationCholesterolNeurologicTissuesLeadMass Spectrum AnalysisBile AcidsLipidomicsLiverHuman DiseaseAnimal ModelGenesMutationPhenotype
Grant awards (22)
Impact of benzalkonium chloride on gut microbiome and gut-liver interactions$648,691
R01 · FY2025 · ES · contact PI
Contribution of altered cell envelope metabolism to resistance to cell envelope-targeting antimicrobials in MRSA$550,162
R01 · FY2025 · AI
Interactions between metabolism, transport, and toxicity of benzalkonium chlorides$463,606
R01 · FY2025 · ES · contact PI
Drug Action, Metabolism and Kinetics Training Grant$352,624
T32 · FY2025 · GM
Impact of benzalkonium chloride on gut microbiome and gut-liver interactions$648,691
R01 · FY2024 · ES · contact PI
Contribution of altered cell envelope metabolism to resistance to cell envelope-targeting antimicrobials in MRSA$550,162
R01 · FY2024 · AI
Interactions between metabolism, transport, and toxicity of benzalkonium chlorides$463,606
R01 · FY2024 · ES · contact PI
Elucidate the mechanisms of ferroptosis mediated by nonconjugated and conjugated polyunsaturated fatty acids$414,979
R21 · FY2024 · AT · contact PI
Contribution of altered cell envelope metabolism to resistance to cell envelope-targeting antimicrobials in MRSA$550,162
R01 · FY2023 · AI
Interactions between metabolism, transport, and toxicity of benzalkonium chlorides$463,606
R01 · FY2023 · ES · contact PI
Interactions between metabolism, transport, and toxicity of benzalkonium chlorides$463,606
R01 · FY2022 · ES · contact PI
Interactions between metabolism, transport, and toxicity of benzalkonium chlorides$463,606
R01 · FY2021 · ES · contact PI
Oxysterols in SLOS Neurodevelopment: Pathological Role and Therapy$383,278
R01 · FY2021 · HD · contact PI
Oxysterols in SLOS Neurodevelopment: Pathological Role and Therapy$391,101
R01 · FY2020 · HD · contact PI
Oxysterols in SLOS Neurodevelopment: Pathological Role and Therapy$391,101
R01 · FY2019 · HD · contact PI
Oxysterols in SLOS Neurodevelopment: Pathological Role and Therapy$391,101
R01 · FY2018 · HD · contact PI
Oxysterols in SLOS Neurodevelopment: Pathological Role and Therapy$389,844
R01 · FY2017 · HD · contact PI
7-Dehydrocholesterol-derived oxysterols in SLOS: role and therapy$249,000
R00 · FY2017 · HD · contact PI
7-Dehydrocholesterol-derived oxysterols in SLOS: role and therapy$246,509
R00 · FY2016 · HD · contact PI
7-Dehydrocholesterol-derived oxysterols in SLOS: role and therapy$249,000
R00 · FY2015 · HD · contact PI
7-Dehydrocholesterol-derived oxysterols in SLOS: role and therapy$107,263
K99 · FY2013 · HD · contact PI
7-Dehydrocholesterol-derived oxysterols in SLOS: role and therapy$107,263
K99 · FY2012 · HD · contact PI